Results 71 to 80 of about 3,222,323 (307)
To build mRNA vaccine manufacturing capacity in Africa, significant progress has been made with human, technical and regulatory capacity development.
Patrick B. Arbuthnot +6 more
doaj +1 more source
We report a case of an infant with HIV receiving raltegravir granules for oral suspension and rifampicin-based TB prophylaxis. Raltegravir trough levels remained subtherapeutic and viral load increased during concurrent rifampicin therapy despite using ...
Marlotte AA van der Veer +6 more
doaj +1 more source
Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini +9 more
wiley +1 more source
Risk of hospitalization for infection syndrome and infection-related mortality comparing HCV patients who received antiviral therapy with those who did not receive antiviral therapy.
Yaa-Hui Dong (3255495) +5 more
core +1 more source
Objective We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAEs and SAEs) in children with newly diagnosed juvenile idiopathic arthritis (JIA) in Canada. Methods We enrolled patients within three months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI ...
Bashayer Alnuaimi +88 more
wiley +1 more source
BACKGROUND/AIMS: The prevalence and clinical implications of non- alcoholic fatty liver disease in patients with chronic hepatitis C remain unknown in Taiwan.
LIU, CHUN-JEN;JENG, YUNG-MING;CHEN, PEI-JER;LAI, MING-YANG;KAO, JIA-HORNG;CHEN, DING-SHINN +1 more
core
Innate Immunocompetent hiPSC‐Derived Neurospheroids Capture Early CNS Responses to rAAV
Knowledge of human CNS immune responses to AAV‐based gene therapies remains limited due to the lack of immune‐competent human models. Here, a hiPSC‐derived 3D neuroimmune platform integrating neurospheroids and microglia is established using stirred‐tank bioreactors.
Catarina M. Gomes +14 more
wiley +1 more source
The patients’ baseline characteristics before antiviral therapy (n = 196).
The patients’ baseline characteristics before antiviral therapy (n = 196).
Michitaka Honda (4672696) +6 more
core +1 more source
Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B [PDF]
BACKGROUND: Large clinical studies assessing long-term adefovir dipivoxil salvage monotherapy in patients with lamivudine-resistant chronic hepatitis B (CHB) are lacking, particularly in patients positive for hepatitis B e antigen (HBeAg).
안상훈 +5 more
core +1 more source
Engineering Microbial Particles for Next‐Generation Biomedical Platforms
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li +7 more
wiley +1 more source

